The Management of Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives

ICIs, ADCs, and targeted therapies are reshaping the therapeutic landscape of MIBC. While early results are promising, further data and biomarker validation are essential to establish their definitive role and guide clinical decision-making in the perioperative setting.

Institutions

Publication Details

Journal
Cancers
Published
2025-12-17
DOI
https://doi.org/10.3390/cancers17244017
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Management of Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives

Cancers
Bladder and Urothelial Cancer Treatments
article

The Management of Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives

article en

Abstract

ICIs, ADCs, and targeted therapies are reshaping the therapeutic landscape of MIBC. While early results are promising, further data and biomarker validation are essential to establish their definitive role and guide clinical decision-making in the perioperative setting.

CancersVol. 17(24)
Vita-Salute San Raffaele University (IT), IRCCS Ospedale San Raffaele (IT), Azienda di Rilievo Nazionale ed Alta Specializzazione (IT), University Hospital Lewisham (GB), Lewisham and Greenwich NHS Trust (GB)
Good health and well-being
Openalex Percentile: Top 28%
Bladder and Urothelial Cancer Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.